# Bespoke Extracts, Inc. > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/en/companies/Bespoke Extracts, Inc.). ## Overview Bespoke Extracts, Inc. is a U.S.-based cannabis products company that operates through its wholly owned subsidiary, Bespoke Extracts Colorado, LLC. The company runs a marijuana-infused products manufacturing facility in Colorado and has shifted its focus from CBD offerings toward regulated cannabis markets in the United States. Its reported operating activity centers on producing and selling pre-rolled joints and providing joint production and processing services to licensed dispensaries and third parties. The business remains small and development-stage in nature, with management emphasizing expansion rather than a mature, diversified operating footprint. ## Products & services • Pre-rolled joints sold to licensed dispensaries • Joint production services for third parties • Processing services for third parties • Marijuana-infused products manufacturing • Extraction and ancillary manufacturing capabilities - **Branded cannabis products** (60%) — Finished cannabis products sold under the company's own product lines, including pre-rolled joints. - **Contract manufacturing and production services** (25%) — Third-party joint production and related manufacturing services performed for other cannabis businesses. - **Processing services** (15%) — Processing work for third parties that use the company's Colorado facility and operational capabilities. - Pre-rolled joints sold to licensed dispensaries - Joint production services for third parties - Processing services for third parties - Marijuana-infused products manufacturing - Extraction and ancillary manufacturing capabilities ## Customers The company's direct customers appear to be licensed dispensaries in Colorado that purchase pre-rolled joints for resale to end consumers. It also serves third-party cannabis businesses that outsource joint production and processing work to Bespoke Extracts Colorado. These customers buy for access to manufacturing capacity, product supply, and regulated cannabis production expertise rather than for broad national distribution. The customer base is concentrated in a regulated, state-level market, which makes licensing status and compliance critical to demand. Because the company is still small, a limited number of commercial relationships likely have a meaningful impact on revenue. - **Licensed dispensaries in Colorado** (primary) — Buy pre-rolled joints for retail resale to adult-use or medical consumers in the Colorado cannabis market. - **Third-party cannabis producers** (secondary) — Outsource joint production and related manufacturing to access capacity and reduce fixed operating costs. - **Processing clients** (secondary) — Use the company's facility for processing services tied to cannabis product preparation and handling. - Licensed dispensaries in Colorado buying pre-rolled joints for resale - Third-party cannabis brands outsourcing joint production - Businesses needing processing capacity in a regulated facility - Customers seeking compliant manufacturing rather than in-house production - State-licensed operators that require cannabis-specific supply chains ## Geography Bespoke Extracts' operating footprint is centered in Colorado, where its manufacturing facility and reported sales activity are located. The company has stated that it intends to expand its focus to regulated cannabis markets in the United States, but the disclosed revenue base remains tied to Colorado. This creates a concentrated exposure to one state market, including local licensing, regulatory, and competitive conditions. Because cannabis is regulated at the state level, geography is not just a sales issue but also a licensing and operating constraint. No country-level revenue breakdown was disclosed in the excerpts provided. - **Colorado** (100%) — Reported sales and manufacturing activity are centered in Colorado. - Colorado is the core operating and sales market - Manufacturing facility is located in Colorado - Sales are tied to licensed dispensaries in Colorado - Expansion target is regulated cannabis markets in the United States - No disclosed international revenue or operating footprint ## Strategy Management's stated strategy is to expand beyond CBD offerings and focus on regulated cannabis markets in the United States. Near term, the company is trying to grow sales through pre-rolled joints, new product introductions, and increased third-party production and processing work. The business also appears to be building around the WonderLeaf asset purchase, which added a marijuana-infused products license, inventory, and extraction equipment. A key strategic issue is funding, because the company has not generated positive operating cash flow and must raise additional capital to continue and expand operations. Execution depends on maintaining regulatory compliance, scaling production, and securing enough capital to support working capital and growth. - **Expand regulated cannabis product focus** (medium-term) — The company is repositioning away from CBD toward higher-opportunity regulated cannabis markets. - **Increase production and service volume** (short-term) — Higher throughput in joints and processing services is the main path to revenue growth in the current model. - **Secure financing and working capital** (short-term) — The company needs external capital to fund operations because it has not generated positive operating cash flow. - Expand from CBD into regulated cannabis markets in the United States - Grow pre-rolled joint sales to licensed dispensaries - Increase third-party joint production and processing services - Use acquired Colorado cannabis assets to support manufacturing capacity - Raise additional capital to fund operations and expansion ## Risks The company faces substantial going-concern and liquidity risk because it has not generated positive operating cash flow and has a working capital deficit. Its reliance on equity and convertible debt financing means operations can be constrained if capital markets are unavailable or expensive. Business risk is also elevated because revenue is concentrated in a single regulated cannabis market, where licensing, compliance, and local competition can change quickly. The company itself highlights potential quarterly volatility, rapid market changes, and the possibility that revenues may not cover operating costs. More generally, cannabis operators face regulatory uncertainty, product demand swings, and supply-chain or manufacturing disruptions that can affect both sales and margins. - **Going-concern uncertainty** [critical] — The company has negative operating cash flow, a working capital deficit, and no committed financing sources. - **Capital raising dependence** [high] — Operations have been funded primarily through equity and convertible debt, which may not be available on acceptable terms. - **Colorado market concentration** [high] — Sales are concentrated in licensed dispensaries in Colorado, making results sensitive to one state market. - **Cannabis regulatory risk** [high] — The business depends on state-level cannabis licensing and compliance, which can change or be restricted. - **Quarterly revenue volatility** [medium] — Management explicitly notes potential fluctuation in quarterly results and rapid market changes. - Going-concern risk due to recurring operating losses and working capital deficit - Financing risk because the company depends on equity and convertible debt - Revenue concentration in Colorado cannabis markets - Regulatory risk tied to state cannabis licensing and compliance - Quarterly volatility from small scale and uneven order flow - Market disruption risk from rapid changes in cannabis demand and competition - Cost pressure from raw materials, packaging, and labor in manufacturing ## Accounting Revenue recognition is a key judgment area because the company sells products and provides production/processing services, which may have different timing for recognizing revenue depending on delivery or service completion. Accounts receivable allowances are important because management explicitly notes credit-loss estimation based on customer-specific information and market conditions, and weaker customers could increase bad debt expense. Inventory accounting is also material because cannabis products and raw materials must be carried at the lower of cost or net realizable value, making valuation sensitive to demand, spoilage, and production efficiency. The company reports a full valuation allowance against deferred tax assets, which means future tax benefits are not currently being recognized in earnings. Stock-based compensation and debt-related financing activities can also affect reported losses and equity, especially for a small company that relies on external funding. - **Revenue recognition** — Affects quarterly revenue timing and comparability - **Accounts receivable allowance** — Can materially affect reported earnings and cash conversion - **Inventory valuation** — Can create write-downs if demand weakens or products become obsolete - **Deferred tax asset valuation allowance** — Prevents recognition of tax assets until profitability is sustained - Revenue recognition timing for product sales versus processing services - Allowance for credit losses on accounts receivable - Inventory valuation at lower of cost or net realizable value - Full valuation allowance against deferred tax assets - Stock-based compensation from consultant and non-employee awards - Debt and convertible financing effects on reported results --- *Last updated: 2026-08-11T04:46:23.600129+00:00*